The azobenzene-containing agonist of the vitamin D receptor, PhotoVDRM, enables spatiotemporal psoriasis treatment in mice; its <i>cisoid</i> form induces potent anti-inflammation without hypercalcemia. Here, VDR is linked to hypercalcemia disease.